What does CUSIP 87650L103 represent in this 13F holders report?

CUSIP 87650L103 is the security identifier for TARS - Tarsus Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in Q4 2023?

114 institutional investors reported TARS - Tarsus Pharmaceuticals, Inc. - Common Stock for Q4 2023. Use the holders table for investor-level position and value details.

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

CUSIP: 87650L103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock
Shares outstanding: 42,450,857
Total 13F shares: 32,126,860
Share change: +2,268,590
Total reported value: $650,570,328
Put/Call ratio: 16%
Price per share: $20.25
Number of holders: 114
Value change: +$49,625,202
Number of buys: 72
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 87650L103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F 3/4/5	Company · 10%+ Owner	6.8%	2,880,701	$51,190,057	—	30 Sep 2023	13F 3/4/5
Vivo Capital IX, LLC	3/4/5	10%+ Owner	— class O/S missing	2,469,001	$49,380,020	—	05 May 2022	3/4/5
Cormorant Asset Management, LP	13F	Company	6.2%	2,621,422	$46,582,669	—	30 Sep 2023	13F
Vivo Capital, LLC	13F	Company	5.3%	2,262,200	$40,199,294	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	5.2%	2,210,323	$39,277,442	—	30 Sep 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	5%	2,140,586	$38,038,213	—	30 Sep 2023	13F
COWEN AND COMPANY, LLC	13F	Company	4.2%	1,796,773	$31,928,656	—	30 Sep 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	4.2%	1,787,527	$31,764,355	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	3.7%	1,551,802	$27,575,522	—	30 Sep 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.1%	1,296,416	$23,037,312	—	30 Sep 2023	13F
TCG Crossover Management, LLC	13F	Company	2.7%	1,142,857	$20,308,569	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.9%	808,161	$14,361,021	—	30 Sep 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.8%	754,042	$13,399,326	—	30 Sep 2023	13F
Tetragon Partners GP Ltd	13F	Company	1.4%	615,000	$10,928,550	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	1.3%	544,932	$9,683,442	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	526,260	$9,352,843	—	30 Sep 2023	13F
Ikarian Capital, LLC	13F	Company	1.2%	518,519	$9,214,083	—	30 Sep 2023	13F
Ensign Peak Advisors, Inc	13F	Company	1%	437,891	$7,781,323	—	30 Sep 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.94%	400,000	$7,108,000	—	30 Sep 2023	13F
Artisan Partners Limited Partnership	13F	Company	0.94%	399,177	$7,093,375	—	30 Sep 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.94%	398,641	$7,084,000	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.84%	355,683	$6,319,416	—	30 Sep 2023	13F
Jefferies Financial Group Inc.	13F	Company	0.78%	330,758	$5,877,570	—	30 Sep 2023	13F
Sands Capital Alternatives, LLC	13F	Company	0.61%	260,000	$4,620,200	—	30 Sep 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.59%	250,000	$4,442,500	—	30 Sep 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.58%	245,972	$4,370,922	—	30 Sep 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.58%	244,155	$4,338,634	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.5%	211,290	$3,754,623	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	188,394	$3,347,761	—	30 Sep 2023	13F
MACQUARIE GROUP LTD	13F	Company	0.35%	150,000	$2,666,000	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.34%	143,292	$2,546,298	—	30 Sep 2023	13F
Nantahala Capital Management, LLC	13F	Company	0.32%	135,500	$2,407,835	—	30 Sep 2023	13F
J. Goldman & Co LP	13F	Company	0.3%	125,909	$2,237,403	—	30 Sep 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.26%	111,772	$1,986,188	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.25%	106,900	$1,900,000	—	30 Sep 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.25%	105,660	$1,877,578	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.25%	105,601	$1,876,530	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.24%	100,062	$1,778,102	—	30 Sep 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.23%	99,300	$1,764,561	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.17%	73,819	$1,311,765	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.17%	71,452	$1,269,702	—	30 Sep 2023	13F
SEI INVESTMENTS CO	13F	Company	0.15%	63,613	$1,130,403	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.14%	61,100	$1,085,747	—	30 Sep 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.13%	55,262	$982,006	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.13%	54,098	$961,321	—	30 Sep 2023	13F
Grant/GrossMendelsohn, LLC	13F	Company	0.13%	53,610	$952,650	—	30 Sep 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.13%	53,305	$947,230	—	30 Sep 2023	13F
SG Americas Securities, LLC	13F	Company	0.12%	50,713	$901,000	—	30 Sep 2023	13F
CIBC WORLD MARKETS CORP	13F	Company	0.12%	50,000	$888,500	—	30 Sep 2023	13F
Ghisallo Capital Management LLC	13F	Company	0.12%	50,000	$888,500	—	30 Sep 2023	13F

Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q4 2023

As of 31 Dec 2023, Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,126,860 shares. The largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., Cormorant Asset Management, LP, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, COWEN AND COMPANY, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, VANGUARD GROUP INC, and PERCEPTIVE ADVISORS LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

105

Q4 2023 holders

114

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.